Edition:
United States

Xvivo Perfusion AB (XVIVO.ST)

XVIVO.ST on Stockholm Stock Exchange

90.50SEK
20 Feb 2018
Change (% chg)

-0.20kr (-0.22%)
Prev Close
90.70kr
Open
91.50kr
Day's High
91.50kr
Day's Low
89.00kr
Volume
7,481
Avg. Vol
26,159
52-wk High
108.00kr
52-wk Low
78.25kr

Chart for

About

Xvivo Perfusion AB is a Sweden-based medical technology company focused on developing optimized solutions for organ, tissue and cell preservation in connection with transplantation. The Company operates in two segments: Durable goods and Non-Durable goods. The Durable goods segment comprises sale and rental income from XVIVO... (more)

Overall

Beta: 0.54
Market Cap(Mil.): kr2,375.48
Shares Outstanding(Mil.): 26.19
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 50.97 17.28
EPS (TTM): -- -- --
ROI: -- 14.13 35.61
ROE: -- 16.74 17.17

BRIEF-Xvivo Perfusion AB Net Sales Of Non-Durable Goods In Q4 Amounted To Sek 39.4 (34.6) Million

* NET SALES OF NON-DURABLE GOODS IN Q4 AMOUNTED TO SEK 39.4 (34.6) MILLION

Feb 09 2018

BRIEF-Xvivo Q3 EBITDA ex-items at SEK 4.4 million

* Q3 NET SALES SEK ‍32.3​ MILLION VERSUS SEK 31.7 MILLION YEAR AGO

Oct 27 2017

Earnings vs. Estimates